Key points are not available for this paper at this time.
Taken together, our findings suggest that restoration of miR-1 gene expression is a potential novel therapeutic strategy to reverse pressure-induced cardiac hypertrophy and prevent maladaptive cardiac remodeling.
Karakikes et al. (Tue,) studied this question.